Cite
MLA Citation
Fabrizio Cantini et al.. “Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study.” Journal of infection, vol. 81, no. 4, 2020, pp. 647–679. http://access.bl.uk/ark:/81055/vdc_100113052382.0x000043
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fabrizio Cantini et al.. “Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study.” Journal of infection, vol. 81, no. 4, 2020, pp. 647–679. http://access.bl.uk/ark:/81055/vdc_100113052382.0x000043